Anthonie WA Lensing

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Martin H. Prins, Anthonie WA Lensing, Rupert Bauersachs et al. · Thrombosis Journal · 2013 · 553 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program

Norikazu Yamada, Atsushi Hirayama, Hideaki Maeda et al. · Thrombosis Journal · 2015 · 109 citations · Full text

Medicine, Hematology, Pharmacology +15

Deep Vein Thrombosis: New Non-Invasive Diagnostic Tests

Harry R. Büller, Anthonie WA Lensing, Jack Hirsh et al. · Thrombosis and Haemostasis · 1991 · 66 citations

Medicine, Hematology, Surgery +13

Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

Rupert Bauersachs, Anthonie WA Lensing, Martin H. Prins et al. · Thrombosis Journal · 2014 · 65 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients

Alexander GG Turpie, Anthonie WA Lensing, Takeshi Fuji et al. · Blood Coagulation & Fibrinolysis · 2009 · 52 citations

Pharmacy, Pharmacokinetics, Pharmacology +17